PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 06, 2025 16:05 ET | Source: PolyPid Ltd. PETACH TIKVA, Israel, June…
HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas
ROTTERDAM, Netherlands, June 6, 2025 /PRNewswire/ -- Thousands of health and technology…
DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer
TROPION-Lung02 and TROPION-Lung04 phase 1b results support combination of Daiichi Sankyo and…
ValueLabs Announces Strategic Pivot–Exclusively Offering Outcome-Based Engagements Globally
Company shifts away from Time & Materials contracts for all new clients,…
Intellipaat & iHub IIT Roorkee Empower Thousands of UI/UX Learners with Industry-Recognised Certification
BENGALURU, India, May 28, 2025 /PRNewswire/ -- In a major milestone for…
PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR
PROVISION Study, Prospective Randomized Trial Evaluating Clinical Outcomes of FFRangio Versus FFR…
Firstsource and Sanas partner to redefine customer conversations with AI
MUMBAI, India, May 22, 2025 /PRNewswire/ -- Firstsource Solutions Limited (NSE:FSL) (BSE:532809), a…
Exterro Cracks the Code for Partners Aiming to Drive Sustainable Revenue Growth in the Data Risk Management Market with Launch of ExPN – the Exterro Partner Network
ExPN members avoid the challenges of offering disparate point products with exclusive…
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patientswith Mild…
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Slowing of progression of disease observed via MRI at 24 months Improvements…